GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (STU:R5XA) » Definitions » Sale Of Investment

Talphera (STU:R5XA) Sale Of Investment : €1.38 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Talphera Sale Of Investment?

Talphera's sale of investment for the three months ended in Mar. 2024 was €1.38 Mil. It means Talphera gained €1.38 Mil from selling investments. Talphera's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €1.38 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2023 ), Talphera gained more money from selling investments in Mar. 2024 (€1.38 Mil).


Talphera Sale Of Investment Historical Data

The historical data trend for Talphera's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Sale Of Investment Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 60.28 66.26 41.58 43.77 0.46

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 - - - 1.38

Talphera Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Talphera Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Talphera's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Talphera (STU:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (STU:R5XA) Headlines

No Headlines